Mutational landscape of non-functional adrenocortical adenomas

in Endocrine-Related Cancer
Authors:
Luming Wu Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China

Search for other papers by Luming Wu in
Current site
Google Scholar
PubMed Close
https://orcid.org/0000-0002-5000-0397
,
Jing Xie Department of Pathology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China

Search for other papers by Jing Xie in
Current site
Google Scholar
PubMed Close
https://orcid.org/0000-0003-3278-2812
,
Yan Qi Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China

Search for other papers by Yan Qi in
Current site
Google Scholar
PubMed Close
https://orcid.org/0000-0003-4316-8922
,
Tingwei Su Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China

Search for other papers by Tingwei Su in
Current site
Google Scholar
PubMed Close
https://orcid.org/0000-0001-6472-3492
,
Lei Jiang Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China

Search for other papers by Lei Jiang in
Current site
Google Scholar
PubMed Close
https://orcid.org/0000-0002-0423-1282
,
Weiwei Zhou Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China

Search for other papers by Weiwei Zhou in
Current site
Google Scholar
PubMed Close
https://orcid.org/0000-0003-2003-7743
,
Yiran Jiang Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China

Search for other papers by Yiran Jiang in
Current site
Google Scholar
PubMed Close
https://orcid.org/0000-0003-2078-8125
,
Cui Zhang Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China

Search for other papers by Cui Zhang in
Current site
Google Scholar
PubMed Close
https://orcid.org/0000-0002-1847-9991
,
Xu Zhong Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China

Search for other papers by Xu Zhong in
Current site
Google Scholar
PubMed Close
https://orcid.org/0000-0002-2175-3437
,
Yanan Cao Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China

Search for other papers by Yanan Cao in
Current site
Google Scholar
PubMed Close
https://orcid.org/0000-0002-3848-7040
, and
Weiqing Wang Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China

Search for other papers by Weiqing Wang in
Current site
Google Scholar
PubMed Close
https://orcid.org/0000-0001-6027-3084

Correspondence should be addressed to W Wang: wqingw61@163.com

*(L Wu, J Xie and Y Qi contributed equally to this work)

DOI:
https://doi.org/10.1530/ERC-21-0410
Volume/Issue:
Volume 29: Issue 9
Article Type:
Research Article
Page Range:
521–532
Online Publication Date:
19 Jul 2022
Copyright:
© Society for Endocrinology 2022
ERRATUM TO THIS ARTICLE
Restricted access
Rent on DeepDyve

Sign up for journal news

Adrenal incidentalomas are the most frequent human neoplasms. Recent genomic investigations on functional adrenocortical tumors have demonstrated that somatic mutations in PRKACA and KCNJ5 responsible for the development of adrenocortical adenomas (ACAs) are associated with hypercortisolism and aldosteronism, respectively. Several studies have identified CTNNB1 mutations in ACAs and have been mostly involved in the tumorigenesis of non-functional ACA (NFACA). However, integrated genomic characterization of NFACAs is lacking. In the current study, we utilized pan-genomic methods to comprehensively analyze 60 NFACA samples. A total of 1264 somatic mutations in coding regions among the 60 samples were identified, with a median of 15 non-silent mutations per tumor. Twenty-two NFACAs (36.67%) had genetic alterations in CTNNB1. We also identified several somatic mutations in genes of the cAMP/PKA pathway and KCNJ5. Histone modification genes (KMT2A, KMT2C, and KMT2D) were altered in 10% of cases. Germline mutations of MEN1 and RET were also found. Finally, by comparison of our transcriptome data with those available in the TCGA, we illustrated the molecular characterization of NFACA. We revealed the genetic profiling and molecular landscape of NFACA. Wnt/β-catenin pathway activation as shown ssby nuclear and/or cytoplasmic β-catenin accumulation is frequent, occurring in about one–third of ACA cases. cytochrome P450 enzymes could be markers to reveal the functional status of adrenocortical tumors. These observations strongly suggest the involvement of the Wnt/β-catenin pathway in benign adrenal tumorigenesis and possibly in the regulation of steroid secretion.

Endocrine-Related Cancer is committed to supporting researchers in demonstrating the impact of their articles published in the journal.

The two types of article metrics we measure are (i) more traditional full-text views and pdf downloads, and (ii) Altmetric data, which shows the wider impact of articles in a range of non-traditional sources, such as social media.

More information is on the Reasons to publish page.

Sept 2018 onwards Past Year Past 30 Days
Full Text Views 389 75 2
PDF Downloads 284 60 3

 

  • Collapse
  • Expand
Print ISSN:
1351-0088
Online ISSN:
1479-6821
Copyright:
© Society for Endocrinology 2022
Page(s):
12
Received Date:
11 Jun 2022
Accepted Date:
22 Jun 2022
Print Publication Date:
01 Sep 2022
Online Publication Date:
19 Jul 2022
Keywords:
adrenal cortex; molecular genetics; adenoma

  • Beuschlein F, Fassnacht M, Assié G, Calebiro D, Stratakis CA, Osswald A, Ronchi CL, Wieland T, Sbiera S, Faucz FR, et al.2014 Constitutive activation of PKA catalytic subunit in adrenal Cushing’s syndrome. New England Journal of Medicine 370 1019–1028. (https://doi.org/10.1056/NEJMoa1310359)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Bonnet S, Gaujoux S, Launay P, Baudry C, Chokri I, Ragazzon B, Libé R, René-Corail F, Audebourg A, Vacher-Lavenu MC, et al.2011 Wnt/β-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and -nonsecreting tumors. Journal of Clinical Endocrinology and Metabolism 96 E419–E426. (https://doi.org/10.1210/jc.2010-1885)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Boulkroun S, Beuschlein F, Rossi GP, Golib-Dzib JF, Fischer E, Amar L, Mulatero P, Samson-Couterie B, Hahner S, Quinkler M, et al.2012 Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism. Hypertension 59 592–598. (https://doi.org/10.1161/HYPERTENSIONAHA.111.186478)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Cancer Genome Atlas Research Network 2014 Integrated genomic characterization of papillary thyroid carcinoma. Cell 159 676–690. (https://doi.org/10.1016/j.cell.2014.09.050)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Cao Y, He M, Gao Z, Peng Y, Li Y, Li L, Zhou W, Li X, Zhong X, Lei Y, et al.2014 Activating hotspot L205R mutation in PRKACA and adrenal Cushing’s syndrome. Science 344 913–917. (https://doi.org/10.1126/science.1249480)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Castellone MD, Verrienti A, Magendra Rao D, Sponziello M, Fabbro D, Muthu M, Durante C, Maranghi M, Damante G, Pizzolitto S, et al.2010 A novel de novo germline V292M mutation in the extracellular region of RET in a patient with phaeochromocytoma and medullary thyroid carcinoma: functional characterization. Clinical Endocrinology 73 529–534. (https://doi.org/10.1111/j.1365-2265.2009.03757.x)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Choi M, Scholl UI, Yue P, Björklund P, Zhao B, Nelson-Williams C, Ji W, Cho Y, Patel A, Men CJ, et al.2011 K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science 331 768–772. (https://doi.org/10.1126/science.1198785)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Cibulskis K, Lawrence MS, Carter SL, Sivachenko A, Jaffe D, Sougnez C, Gabriel S, Meyerson M, Lander ES & Getz G 2013 Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nature Biotechnology 31 213–219. (https://doi.org/10.1038/nbt.2514)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Di Dalmazi G, Kisker C, Calebiro D, Mannelli M, Canu L, Arnaldi G, Quinkler M, Rayes N, Tabarin A, Laure Jullié M, et al.2014 Novel somatic mutations in the catalytic subunit of the protein kinase a as a cause of adrenal Cushing’s syndrome: a European multicentric study. Journal of Clinical Endocrinology and Metabolism 99 E2093–E2100. (https://doi.org/10.1210/jc.2014-2152)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Durand J, Lampron A, Mazzuco TL, Chapman A & Bourdeau I 2011 Characterization of differential gene expression in adrenocortical tumors harboring beta-catenin (CTNNB1) mutations. Journal of Clinical Endocrinology and Metabolism 96 E1206–E1211. (https://doi.org/10.1210/jc.2010-2143)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Fassnacht M, Arlt W, Bancos I, Dralle H, Newell-Price J, Sahdev A, Tabarin A, Terzolo M, Tsagarakis S & Dekkers OM 2016 Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. European Journal of Endocrinology 175 G1–G34. (https://doi.org/10.1530/EJE-16-0467)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Gatta-Cherifi B, Chabre O, Murat A, Niccoli P, Cardot-Bauters C, Rohmer V, Young J, Delemer B, Du Boullay H, Verger MF, et al.2012 Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d'etude des Tumeurs Endocrines database. European Journal of Endocrinology 166 269–279. (https://doi.org/10.1530/EJE-11-0679)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Gaujoux S, Tissier F, Groussin L, Libé R, Ragazzon B, Launay P, Audebourg A, Dousset B, Bertagna X & Bertherat J 2008 Wnt/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate/protein kinase a signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors. Journal of Clinical Endocrinology and Metabolism 93 4135–4140. (https://doi.org/10.1210/jc.2008-0631)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Goh G, Scholl UI, Healy JM, Choi M, Prasad ML, Nelson-Williams C, Kunstman JW, Korah R, Suttorp AC, Dietrich D, et al.2014 Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors. Nature Genetics 46 613–617. (https://doi.org/10.1038/ng.2956)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Hansel DE & Reuter VE 2016 Adrenal pathology in the adult: a urological pathologist's perspective. Advances in Anatomic Pathology 23 273–284. (https://doi.org/10.1097/PAP.0000000000000120)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Kim D, Langmead B & Salzberg SL 2015 HISAT: a fast spliced aligner with low memory requirements. Nature Methods 12 357–360. (https://doi.org/10.1038/nmeth.3317)

  • Krivtsov AV & Armstrong SA 2007 MLL translocations, histone modifications and leukaemia stem-cell development. Nature Reviews: Cancer 7 823–833. (https://doi.org/10.1038/nrc2253)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Langmead B, Trapnell C, Pop M & Salzberg SL 2009 Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biology 10 R25. (https://doi.org/10.1186/gb-2009-10-3-r25)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Lenzini L, Rossitto G, Maiolino G, Letizia C, Funder JW & Rossi GP 2015 A meta-analysis of somatic KCNJ5 K(+) channel mutations in 1636 patients with an aldosterone-producing adenoma. Journal of Clinical Endocrinology and Metabolism 100 E1089–E1095. (https://doi.org/10.1210/jc.2015-2149)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Li H & & Durbin R 2009 Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25 1754–1760. (https://doi.org/10.1093/bioinformatics/btp324)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Li B & & Dewey CN 2011 RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics 12 323. (https://doi.org/10.1186/1471-2105-12-323)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly M, et al.2010 The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Research 20 1297–1303. (https://doi.org/10.1101/gr.107524.110)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Monticone S, Castellano I, Versace K, Lucatello B, Veglio F, Gomez-Sanchez CE, Williams TA & Mulatero P 2015 Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas. Molecular and Cellular Endocrinology 411 146–154. (https://doi.org/10.1016/j.mce.2015.04.022)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Morelli V, Reimondo G, Giordano R, Della Casa S, Policola C, Palmieri S, Salcuni AS, Dolci A, Mendola M, Arosio M, et al.2014 Long-term follow-up in adrenal incidentalomas: an Italian multicenter study. Journal of Clinical Endocrinology and Metabolism 99 827–834. (https://doi.org/10.1210/jc.2013-3527)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Nanba K, Chen AX, Omata K, Vinco M, Giordano TJ, Else T, Hammer GD, Tomlins SA & Rainey WE 2016 Molecular heterogeneity in aldosterone-producing adenomas. Journal of Clinical Endocrinology and Metabolism 101 999–1007. (https://doi.org/10.1210/jc.2015-3239)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Nielsen HM, How-Kit A, Guerin C, Castinetti F, Vollan HK, De Micco C, Daunay A, Taieb D, Van Loo P, Besse C, et al.2015 Copy number variations alter methylation and parallel IGF2 overexpression in adrenal tumors. Endocrine-Related Cancer 22 953–967. (https://doi.org/10.1530/ERC-15-0086)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM & Montori VM 2008 The diagnosis of Cushing’s syndrome: an Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism 93 1526–1540. (https://doi.org/10.1210/jc.2008-0125)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Omata K, Yamazaki Y, Nakamura Y, Anand SK, Barletta JA, Sasano H, Rainey WE, Tomlins SA & Vaidya A 2017 Genetic and histopathologic intertumor heterogeneity in primary aldosteronism. Journal of Clinical Endocrinology and Metabolism 102 1792–1796. (https://doi.org/10.1210/jc.2016-4007)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Plouin PF, Amar L, Dekkers OM, Fassnacht M, Gimenez-Roqueplo AP, Lenders JW, Lussey-Lepoutre C, Steichen O & Guideline Working Group 2016 European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma. European Journal of Endocrinology 174 G1–G10. (https://doi.org/10.1530/EJE-16-0033)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Ramos AH, Lichtenstein L, Gupta M, Lawrence MS, Pugh TJ, Saksena G, Meyerson M & Getz G 2015 Oncotator: cancer variant annotation tool. Human Mutation 36 E2423–E2429. (https://doi.org/10.1002/humu.22771)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Ronchi CL, Di Dalmazi G, Faillot S, Sbiera S, Assié G, Weigand I, Calebiro D, Schwarzmayr T, Appenzeller S, Rubin B, et al.2016 Genetic landscape of sporadic unilateral adrenocortical adenomas without PRKACA p.Leu206Arg mutation. Journal of Clinical Endocrinology and Metabolism 101 3526–3538. (https://doi.org/10.1210/jc.2016-1586)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Rubinstein JC, Brown TC, Goh G, Juhlin CC, Stenman A, Korah R & Carling T 2016 Chromosome 19 amplification correlates with advanced disease in adrenocortical carcinoma. Surgery 159 296–301. (https://doi.org/10.1016/j.surg.2015.09.001)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Sato Y, Maekawa S, Ishii R, Sanada M, Morikawa T, Shiraishi Y, Yoshida K, Nagata Y, Sato-Otsubo A, Yoshizato T, et al.2014 Recurrent somatic mutations underlie corticotropin-independent Cushing’s syndrome. Science 344 917–920. (https://doi.org/10.1126/science.1252328)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Saunders CT, Wong WS, Swamy S, Becq J, Murray LJ & Cheetham RK 2012 Strelka: accurate somatic small-variant calling from sequenced tumor–normal sample pairs. Bioinformatics 28 1811–1817. (https://doi.org/10.1093/bioinformatics/bts271)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Sidhu S, Marsh DJ, Theodosopoulos G, Philips J, Bambach CP, Campbell P, Magarey CJ, Russell CF, Schulte KM, Röher HD, et al.2002 Comparative genomic hybridization analysis of adrenocortical tumors. Journal of Clinical Endocrinology and Metabolism 87 3467–3474. (https://doi.org/10.1210/jcem.87.7.8697)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Stratakis CA 2014 E pluribus unum? The main protein kinase a catalytic subunit (PRKACA), a likely oncogene, and cortisol-producing tumors. Journal of Clinical Endocrinology and Metabolism 99 3629–3633. (https://doi.org/10.1210/jc.2014-3295)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Thakker RV 2010 Multiple endocrine neoplasia type 1 (MEN1). Best Practice and Research: Clinical Endocrinology and Metabolism 24 355–370. (https://doi.org/10.1016/j.beem.2010.07.003)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Tissier F, Cavard C, Groussin L, Perlemoine K, Fumey G, Hagneré AM, René-Corail F, Jullian E, Gicquel C, Bertagna X, et al.2005 Mutations of β-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors. Cancer Research 65 7622–7627. (https://doi.org/10.1158/0008-5472.CAN-05-0593)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Tiu SC, Choi CH, Shek CC, Ng YW, Chan FK, Ng CM & Kong AP 2005 The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling. Journal of Clinical Endocrinology and Metabolism 90 72–78. (https://doi.org/10.1210/jc.2004-1149)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Wu VC, Wang SM, Chueh SJ, Yang SY, Huang KH, Lin YH, Wang JJ, Connolly R, Hu YH, Gomez-Sanchez CE, et al.2017 The prevalence of CTNNB1 mutations in primary aldosteronism and consequences for clinical outcomes. Scientific Reports 7 39121. (https://doi.org/10.1038/srep39121)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Young Jr. WF 2007 Clinical practice. The incidentally discovered adrenal mass. New England Journal of Medicine 356 601–610. (https://doi.org/10.1056/NEJMcp065470)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Zheng S, Cherniack AD, Dewal N, Moffitt RA, Danilova L, Murray BA, Lerario AM, Else T, Knijnenburg TA, Ciriello G, et al.2016 Comprehensive pan-genomic characterization of adrenocortical carcinoma. Cancer Cell 29 723–736. (https://doi.org/10.1016/j.ccell.2016.04.002)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Zhou W, Wu L, Xie J, Su T, Jiang L, Jiang Y, Cao Y, Liu J, Ning G & Wang W 2016 Steroidogenic acute regulatory protein overexpression correlates with protein kinase a activation in adrenocortical adenoma. PLoS ONE 11 e0162606. (https://doi.org/10.1371/journal.pone.0162606)

    • PubMed
    • Search Google Scholar
    • Export Citation